Teva Pharmaceutical Industries Limited logo
Teva Pharmaceutical Industries Limited TEVA
$ 21.92 2.86%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Teva Pharmaceutical Industries Limited Income Statement 2011-2024 | TEVA

Annual Income Statement Teva Pharmaceutical Industries Limited

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

14.5 B 11.4 B 9.29 B 12.9 B 11.2 B 20.4 B 21 B 31.9 B 49.4 B 44.6 B 34.7 B 28.3 B 33.8 B

Shares

1.12 B 1.11 B 1.1 B 1.1 B 1.09 B 1.02 B 1.02 B 955 M 855 M 853 M 849 M 872 M 890 M

Historical Prices

13 10.3 8.43 11.8 10.4 19.9 20.3 32 57.5 52 39.6 32.7 38

Net Income

-559 M -1.3 B 417 M -3.99 B -999 M -2.15 B -16.3 B 329 M 1.59 B 3.06 B 1.27 B 1.96 B 2.76 B

Revenue

15.8 B 14.9 B 15.9 B 16.7 B 16.9 B 18.9 B 22.4 B 21.9 B 19.7 B 20.3 B 20.3 B 20.3 B 18.3 B

Cost of Revenue

8.2 B 7.95 B 8.28 B 8.93 B 9.35 B 9.98 B 11.2 B 10.2 B 8.3 B 9.22 B 9.61 B 9.66 B 8.8 B

Gross Profit

7.64 B 6.97 B 7.59 B 7.73 B 7.54 B 8.3 B 10.8 B 11.9 B 11.4 B 11.1 B 10.7 B 10.7 B 9.52 B

Operating Income

433 M -940 M 1.72 B -3.57 B -443 M -1.64 B -17.5 B 2.15 B 3.35 B 3.95 B 1.65 B 2.2 B 3.11 B

Interest Expense

1.03 B 930 M 891 M 901 M 822 M 920 M 875 M 546 M 270 M 300 M 314 M 355 M 234 M

EBITDA

1.59 B 368 M 3.05 B -2.02 B 1.28 B 205 M 6.1 B 6.18 B 6.42 B 6 B 5.6 B 5.89 B 5.08 B

Operating Expenses

- - - - 4.79 B 5.41 B 6.83 B 7.21 B 6.24 B 6.57 B 6.75 B 6.47 B 5.5 B

General and Administrative Expenses

1.16 B 1.18 B 1.1 B 1.17 B 1.19 B 1.3 B 1.33 B 1.24 B 1.24 B 1.22 B 1.24 B 1.24 B 932 M

All numbers in USD currency

Quarterly Income Statement Teva Pharmaceutical Industries Limited

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

1.13 B 1.13 B 1.12 B 1.12 B 1.12 B 1.12 B - 1.11 B 1.11 B 1.11 B - 1.1 B 1.1 B 1.1 B - 1.1 B 1.1 B 1.09 B - 1.09 B 1.09 B 1.09 B - 1.02 B 1.02 B 1.02 B - 1.02 B 1.02 B 1.02 B - 979 M 914 M 913 M - 851 M 849 M 851 M - 855 M 852 M 850 M - 845 M 849 M 855 M - 869 M 871 M 880 M - 888 M 892 M 897 M

Net Income

-437 M -846 M -139 M 69 M -872 M -220 M - 56 M -232 M -955 M - 292 M 207 M 77 M 150 M -4.35 B 140 M 69 M 110 M -314 M -689 M -105 M -2.89 B -208 M -176 M 1.12 B -11.5 B 595 M -5.97 B 645 M - 412 M 254 M 636 M - 103 M 539 M 446 M - 876 M 748 M 744 M - 711 M -452 M 630 M - -79 M 863 M 859 M - 916 M 576 M 761 M

Revenue

4.33 B 4.16 B 3.82 B 3.85 B 3.88 B 3.66 B - 3.6 B 3.79 B 3.66 B - 3.89 B 3.91 B 3.98 B 4.45 B 3.98 B 3.87 B 4.36 B 4.47 B 4.09 B 4.18 B 4.15 B 4.42 B 4.38 B 4.55 B 5.06 B 5.46 B 5.61 B 5.72 B 5.65 B 6.49 B 5.56 B 5.04 B 4.81 B - 4.82 B 4.97 B 4.98 B - 5.06 B 5.04 B 5 B - 5.06 B 4.92 B 4.9 B - 4.97 B 4.99 B 4.99 B - 4.34 B 4.21 B 4.08 B

Cost of Revenue

2.18 B 2.14 B 2.05 B 2 B 2.08 B 2.08 B - 1.93 B 1.99 B 1.92 B - 2.09 B 2.04 B 2.1 B - 2.13 B 2.11 B 2.29 B - 2.26 B 2.28 B 2.29 B - 2.55 B 2.67 B 2.75 B - 2.97 B 2.86 B 2.81 B - 2.76 B 2.16 B 2.02 B - 2.05 B 2.06 B 2.15 B - 2.25 B 2.38 B 2.3 B - 2.43 B 2.33 B 2.31 B - 2.37 B 2.34 B 2.49 B - 2.1 B 2.01 B 1.89 B

Gross Profit

2.15 B 2.02 B 1.77 B 1.85 B 1.8 B 1.58 B - 1.67 B 1.79 B 1.74 B - 1.79 B 1.87 B 1.88 B 2.05 B 1.85 B 1.76 B 2.06 B 1.96 B 1.83 B 1.89 B 1.86 B 1.97 B 1.98 B 2.03 B 2.32 B 2.44 B 2.6 B 2.8 B 2.77 B 3.39 B 2.8 B 2.88 B 2.79 B - 2.77 B 2.9 B 2.84 B - 2.81 B 2.66 B 2.7 B - 2.63 B 2.59 B 2.59 B - 2.6 B 2.66 B 2.61 B - 2.25 B 2.2 B 2.19 B

Operating Income

-51 M -5 M -218 M 344 M -654 M -13 M - 419 M -949 M -713 M - 623 M 582 M 434 M - -4.34 B 173 M 191 M - -81 M -644 M 134 M - 16 M -14 M 1.52 B - 378 M -5.74 B 895 M - 765 M 361 M 1.16 B - 1.01 B 662 M 749 M - 1.11 B 925 M 972 M - 801 M -586 M 874 M - -60 M 1.01 B 928 M - 1.04 B 597 M 867 M

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

208 M 254 M 54 M 627 M -354 M 291 M - 740 M -591 M -390 M - 1.63 B 755 M 810 M - -3.18 B 954 M 590 M - 1.22 B 249 M 577 M - 1.48 B 972 M 2.03 B - 1.96 B -4.68 B 1.38 B - 765 M 361 M 1.47 B - 1.01 B 662 M 1.08 B - 1.11 B 925 M 1.38 B - 801 M -586 M 1.26 B - -60 M 1.01 B 1.45 B - 1.04 B 597 M 1.13 B

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

298 M 283 M 278 M 268 M 307 M 296 M - 283 M 313 M 296 M - 291 M 242 M 290 M - 279 M 264 M 304 M - 285 M 296 M 292 M - 309 M 316 M 329 M - 372 M 363 M 366 M - 310 M 311 M 304 M - 316 M 325 M 307 M - 293 M 302 M 302 M - 297 M 319 M 307 M - 292 M 316 M 312 M - 112 M 284 M 221 M

All numbers in USD currency